Is ContextVision AB (publ) a good investment? ContextVision AB (publ) (CONTX.OL) is currently trading at 3.60 NOK.
In terms of valuation, the stock trades at a P/E ratio of 368.00. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: ContextVision AB (publ) is expected to release its next earnings report on Aug. 27, 2026. The market consensus estimate for Forward EPS is 0.19.
No, it does not currently pay a dividend.
ContextVision AB (publ) is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Aug. 27, 2026. The company currently has a trailing EPS of 0.01.
ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women's health, veterinary medicine, and point of-care applications. It also provides Altumira platform, which features scatter correction and improves radiography by enabling radiation dose reduction while enhancing image quality, such as Altumira for static applications; and Altumira Plus for dynamic applications. In addition, the company offers image quality solutions for MRI including GOPView MRI2Plus for the requirements of each application, sequence type, and protocol; and implementation projects, software updates, and upgrades and product support services. It has a strategic clinical development partnership with the University of Washington to identify a multiparametric biomarker for the screening and staging of the liver disease MASLD; and research partnership with AMRA Medical. ContextVision AB (publ) was incorporated in 1989 and is headquartered in Stockholm, Sweden.
| Year | Total Dividends |
|---|---|
| 2023 | 0.30 NOK |
| Nov. 10, 2023 | 0.1510 |
| May 16, 2023 | 0.1500 |
| 2008 | 1.28 NOK |
| June 6, 2008 | 1.2800 |
Yearly aggregated dividends
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 19, 2020 | 10.000000 |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion